Literature DB >> 7119441

Properties of a new complement-dependent bactericidal factor specific for Ra chemotype salmonella in sera of conventional and germ-free mice.

M Kawakami, I Ihara, A Suzuki, Y Harada.   

Abstract

A complement-dependent bactericidal factor, Ra-reactive factor, that acts specifically on Ra chemotype strains of Salmonella was found in sera of eighteen strains of nonimmune mice, including a thymusless strain. The specificity of binding of this factor to the cells of Ra chemotype bacteria was evidenced by absorption studies. The factor was inactivated by treatment with 0.02 M 2-mercaptoethanol or heating for 30 min at 55 degrees C. This factor was present in mice reared by feeding with a chemically defined, antigen-free diet under germ-free conditions. Fetal and newborn mice from a conventional or germ-free mother had the factor, although the titer was lower than the adults'. The titer in the newborn mice reached adult level 1 wk after birth. The titer in the adult mice did not increase markedly after immunization with heat-killed bacteria or administration of Freund's complete adjuvant and turpentine. These results indicate that this factor is actively produced by mice that have never been stimulated with exogenous Ra antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7119441

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.

Authors:  R P Darveau; J Blake; C L Seachord; W L Cosand; M D Cunningham; L Cassiano-Clough; G Maloney
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms.

Authors:  M Devyatyarova-Johnson; I H Rees; B D Robertson; M W Turner; N J Klein; D L Jack
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Monoclonal antibodies distinguish phase variants of Coxiella burnetii.

Authors:  J C Williams; M R Johnston; M G Peacock; L A Thomas; S Stewart; J L Portis
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

4.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

5.  A 28,000-dalton protein of normal mouse serum binds specifically to the inner core region of bacterial lipopolysaccharide.

Authors:  L Brade; H Brade
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

Review 6.  Mammalian lectins in activation and clearance mechanisms involving the complement system.

Authors:  K B Reid; M W Turner
Journal:  Springer Semin Immunopathol       Date:  1994

7.  Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns.

Authors:  G Pluschke; M Achtman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

8.  Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing.

Authors:  G Pluschke; J Mayden; M Achtman; R P Levine
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

Review 9.  MBL-associated serine proteases (MASPs) and infectious diseases.

Authors:  Marcia H Beltrame; Angelica B W Boldt; Sandra J Catarino; Hellen C Mendes; Stefanie E Boschmann; Isabela Goeldner; Iara Messias-Reason
Journal:  Mol Immunol       Date:  2015-04-08       Impact factor: 4.407

10.  Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease.

Authors:  M Matsushita; T Fujita
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.